RxDoctor Payments Data

Laura Koonce

Gerontology · Lancaster, PANPI 1780172163

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,608 of the $4,242 with a category attached, or 61.5%. Medtronic accounts for 65.7% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $3,144, 9.3 times the $338 reported in 2021. Among gerontology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,242in general payments, 2019–2025

Across 58 payments — averaging $73.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$283
  • Biosense Webster, Inc.$255
  • Johnson & Johnson$203
  • Pfizer$199
  • Boston Scientific$138
  • plus $374 from 5 others

What the payments were for

  • Travel & lodging$1,63439%
  • Food & beverage$2,60861%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,242 in reported general payments places this provider in the 95th percentile of 383 gerontology providers in Pennsylvania.

See all gerontology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$38,012
Medicare patients
268
Services billed
506

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban455$465,096
XareltoRivaroxaban75$90,021
EntrestoSacubitril/Valsartan56$81,858
JardianceEmpagliflozin52$55,554
MultaqDronedarone Hcl18$37,432
FarxigaDapagliflozin Propanediol16$22,659
Repatha SureclickEvolocumab11$16,976
Dofetilide40$7,496
Metoprolol Succinate375$5,660
VascepaIcosapent Ethyl15$5,215
Atorvastatin Calcium253$3,068
Flecainide Acetate37$2,191
Rosuvastatin Calcium131$2,097
Ezetimibe76$1,857
Amiodarone Hcl96$1,437

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$199$465,096455 claims
Johnson & JohnsonXarelto$203$90,02175 claims
NovartisEntresto$32$81,85856 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 383 gerontology providers in Pennsylvania.

Other gerontology in Lancaster

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →